Moderator:
+ Viveka Roychowdhury, Editor, Express Pharma & Express Healthcare, The Indian Express Group
Panelists in this video:
+ Dr Meka Lingam, Sr VP – Formulation R&D, Lee Pharma
+ Dr Kamal Kumar Upadhyay, VP – Pharma SGI R&D Head (Injectables), Biological E
+ Dr Ravikumar N, VP – R&D, MSN Laboratories
+ Dr Chandresh Chatbar, VP- R&D, CuraTeQ Biologics
Key Highlights:
[1] FR&D scientists have a huge role to play in driving innovation in India Pharma Inc as they strive to offer cost-effective formulations with optimised dosages, and patient-centricity.
[2] So, we need to cultivate and incentivise the right talent to build scientific acumen to accelerate progress in FR&D.
[3] We need robust strategies in place, including right technologies, effective policies, streamlined processes and clear regulatory pathways, to develop novel and complex formulations.
[4] Affordable generics and affordable formulations is India’s USP. But, now we need to drive value through differentiated and novel formulations to accelerate our growth story.
[5] Emerging technologies will help record and document data effectively, choose the right regulatory pathways and commercialise safer formulations faster.